The Oncological Sciences [ONC] Integrated Review Group (IRG) will consider applications involving basic, translational, and clinical investigations that encompass cancer prevention, initiation, promotion, progression, diagnosis and treatment. Specifically, the ONC IRG reviews research grant applications related to chemical carcinogenesis, cancer genetics, nutritional carcinogenesis, radiation effects, and tumor biology; mechanism of action of cancer therapeutic agents in both in vitro and in vivo model systems; development and evaluation of experimental therapies of neoplastic diseases, translation of basic research to clinical practice; development or optimization of treatment modalities; chemoprevention; and development of biomarkers/signatures for tumor detection and diagnosis.
The following Study Sections are included within the ONC IRG:
|